Nihon Kohden to Acquire Majority Stake in NeuroAdvanced for 16 Billion Yen
Nihon Kohden (TYO:6849) is acquiring a majority stake of 71.4% in NeuroAdvanced, the parent company of Ad-Tech Medical Instrument, for about 16 billion yen.
As a result, the medical equipment manufacturer said Ad-Tech will become consolidated and specified subsidiaries of Nihon Kohden, according to its filing on Thursday.
The acquisition involves a stock purchase agreement with NeuroNewCo, a fund which owns 100% shares in NeuroAdvanced, and a shareholders agreement outlining future business operations and potential full acquisition of NeuroAdvanced.
The acquisition is part of Nihon Kohden's long-term vision to solve global medical issues and expand its consumables and services business in North America.
The share transfer is scheduled to take place Nov. 29
Nihon Kohden's shares gained over 2% in early trade.
Price (JPY): $2089.00, Change: $+45, Percent Change: +2.18%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。